Skip to main content

Abstract

Transcranial magnetic stimulation (TMS) is an increasingly popular noninvasive brain stimulation modality. In TMS, a pulsed magnetic field is used to noninvasively stimulate a targeted brain region. Repeated stimulation produces lasting changes in brain activity via mechanisms of synaptic plasticity similar to long-term potentiation. Local application of TMS alters activity in distant, functionally connected brain regions, indicating that TMS modulates activity of cortical networks. TMS has been approved by the U.S. Food and Drug Administration for the treatment of major depressive disorder, obsessive-compulsive disorder, and smoking cessation, and a growing evidence base supports its efficacy in the treatment of other neuropsychiatric conditions. TMS is rapidly becoming part of the standard of care for treatment-resistant depression, where it yields response rates of 40%−60%. TMS is generally safe and well tolerated; its most serious risk is seizure, which occurs very rarely. This review aims to familiarize practicing psychiatrists with basic principles of TMS, including target localization, commonly used treatment protocols and their outcomes, and safety and tolerability. Practical considerations, including evaluation and monitoring of patients undergoing TMS, device selection, treatment setting, and insurance reimbursement, are also reviewed.

Formats available

You can view the full content in the following formats:

Information & Authors

Information

Published In

History

Published in print: Winter 2022
Published online: 25 January 2022

Keywords

  1. Transcranial magnetic stimulation
  2. Repetitive transcranial magnetic stimulation
  3. major depressive disorder
  4. obsessive-compulsive disorder
  5. smoking cessation

Authors

Affiliations

Katharine G. Marder, M.D. [email protected]
Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles (Marder); Division of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Barbour, Ferber); Curated Mental Health, New York City (Idowu, Itzkoff); Yale Stress Center, New Haven, Connecticut (Idowu); Department of Psychiatry, Mount Sinai Hospital, New York City (Itzkoff).
Tracy Barbour, M.D.
Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles (Marder); Division of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Barbour, Ferber); Curated Mental Health, New York City (Idowu, Itzkoff); Yale Stress Center, New Haven, Connecticut (Idowu); Department of Psychiatry, Mount Sinai Hospital, New York City (Itzkoff).
Stephen Ferber, M.D.
Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles (Marder); Division of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Barbour, Ferber); Curated Mental Health, New York City (Idowu, Itzkoff); Yale Stress Center, New Haven, Connecticut (Idowu); Department of Psychiatry, Mount Sinai Hospital, New York City (Itzkoff).
Olanike Idowu, A.P.R.N., P.M.H.N.P.-B.C.
Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles (Marder); Division of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Barbour, Ferber); Curated Mental Health, New York City (Idowu, Itzkoff); Yale Stress Center, New Haven, Connecticut (Idowu); Department of Psychiatry, Mount Sinai Hospital, New York City (Itzkoff).
Amanda Itzkoff, M.D.
Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles (Marder); Division of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston (Barbour, Ferber); Curated Mental Health, New York City (Idowu, Itzkoff); Yale Stress Center, New Haven, Connecticut (Idowu); Department of Psychiatry, Mount Sinai Hospital, New York City (Itzkoff).

Notes

Send correspondence to Dr. Marder ([email protected]).

Competing Interests

The authors report no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Full Text

View Full Text

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Focus

PPV Articles - Focus

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share